Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
Breitkreutz I, Lokhorst HM, Raab MS, Holt Bv, Cremer FW, Herrmann D, Glasmacher A, Schmidt-Wolf IG, Blau IW, Martin H, Salwender H, Haenel A, Sonneveld P, Goldschmidt H. Breitkreutz I, et al. Among authors: cremer fw. Leukemia. 2007 Jun;21(6):1294-9. doi: 10.1038/sj.leu.2404661. Epub 2007 Mar 22. Leukemia. 2007. PMID: 17377586 Clinical Trial.
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J, Herrmann D, Breitkreutz I, Hegenbart U, Mazitschek U, Egerer G, Cremer FW, Lowenthal RM, Huesing J, Fruehauf S, Moehler T, Ho AD, Goldschmidt H. Klaus J, et al. Among authors: cremer fw. Eur J Haematol. 2007 Jan;78(1):21-8. doi: 10.1111/j.0902-4441.2006.t01-1-EJH2895.x. Epub 2006 Sep 28. Eur J Haematol. 2007. PMID: 17042762
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.
Goldschmidt H, Sonneveld P, Cremer FW, van der Holt B, Westveer P, Breitkreutz I, Benner A, Glasmacher A, Schmidt-Wolf IG, Martin H, Hoelzer D, Ho AD, Lokhorst HM; HOVON; GMMG. Goldschmidt H, et al. Among authors: cremer fw. Ann Hematol. 2003 Oct;82(10):654-9. doi: 10.1007/s00277-003-0685-2. Epub 2003 Jul 4. Ann Hematol. 2003. PMID: 12845480 Clinical Trial. No abstract available.
53 results